Brandi, G., Tavolari, S., De Rosa, F., Di Girolamo, S., Agostini, V., Barbera, M. A., . . . Biasco, G. (2012). Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations. Public Library of Science.
Stile di citazione ChicagoBrandi, Giovanni, Simona Tavolari, Francesco De Rosa, Stefania Di Girolamo, Valentina Agostini, Maria Aurelia Barbera, Giorgio Frega, e Guido Biasco. Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations. Public Library of Science, 2012.
Citazione MLABrandi, Giovanni, et al. Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations. Public Library of Science, 2012.